HEMANGEOL- propranolol hydrochloride solution United States - English - NLM (National Library of Medicine)

hemangeol- propranolol hydrochloride solution

pierre fabre pharmaceuticals, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 4.28 mg in 1 ml - hemangeol oral solution contains the beta-adrenergic blocker propranolol hydrochloride and is indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. hemangeol is contraindicated in the following conditions: - premature infants with corrected age < 5 weeks - infants weighing less than 2 kg - known hypersensitivity to propranolol or any of the excipients [see description (11)] - asthma or history of bronchospasm - heart rate <80 beats per minute, greater than first degree heart block, or decompensated heart failure - blood pressure <50/30 mmhg - pheochromocytoma of 460 infants with proliferating infantile hemangioma requiring systemic therapy who were treated with hemangeol starting at 5 weeks to 5 months of age, 60% had complete or nearly complete resolution of their hemangioma at week 24 [see  clinical studies (14)]. safety and effectiveness for infantile hemangioma have not been established in pediatric

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -

JONCIA Australia - English - Department of Health (Therapeutic Goods Administration)

joncia

pierre fabre australia pty ltd - milnacipran hydrochloride -